Korea Arlico Pharm Co.,Ltd. (KOSDAQ: 260660)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,055.00
-5.00 (-0.12%)
Oct 11, 2024, 9:00 AM KST

Korea Arlico Pharm Co.,Ltd. Company Description

Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea.

It offers ETC, OTC, medical device, and other products; and active ingredients. The company provides products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, NSAIDS and analgesics, ointment/cream, respiratory system, gastrointestinal, metabolic disease, antihistamines, anti-virus, genitourinary, alopecia, psychoneurotic, CNS, anthelmintics, and hypnotic diseases.

Korea Arlico Pharm Co.,Ltd. was founded in 1992 and is headquartered in Seoul, South Korea.

Korea Arlico Pharm Co.,Ltd.
Country South Korea
Founded 1992
Industry Pharmaceutical Preparations
Employees 112
CEO Hang-Gu Lee

Contact Details

Address:
Alico Pharmaceutical Building
Seoul
South Korea
Phone 82 2 585 0004
Website arlico.co.kr

Stock Details

Ticker Symbol 260660
Exchange KOSDAQ
Fiscal Year January - December
Reporting Currency KRW
SIC Code 2834

Key Executives

Name Position
Hang-Gu Lee Chief Executive Officer